Endocrinology News

BOSTON — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, discusses her presentation at the Cardiometabolic Health Congress, “Primary Prevention of CVD: The Sooner the Better?”

Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.

At current prices, bariatric surgery was more cost-effective than GLP-1 receptor agonists for treatment of obesity, researchers reported at the American College of Surgeons Clinical Congress.

This year’s American College of Lifestyle Medicine annual conference is taking place in person in Orlando and virtually from Oct. 27 to Oct. 30.

SGLT2 inhibitors and GLP-1 were more effective than dipeptidyl peptidase-4 inhibitors and sulfonylurea kidney complications .

Interest in menopause and all things related to midlife women’s health continues to grow, and The Menopause Society is expanding to meet the demand.

BOSTON — In a survey, cardiology physicians expressed hesitancy to prescribe currently available obesity medications, preferring exercise and dietary interventions, but with little personalized tailoring for patients, researchers reported.

Medtronic has issued an urgent medical device correction letter warning users of the MiniMed 600 and 700 series of insulin pumps of an increased risk for shorter-than-expected battery life, according to an FDA press release.

There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.

Ozempic and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid and alcohol use disorders, a new study showed.